ESG

Sivers Semiconductors unveils new Ka-band chipsets and antennas, promising seamless, high-speed satellite internet for a rapidly growing global market.

With a bolstered cash runway from recent funding, Inventiva is all-in on its MASH drug, lanifibranor, racing against giants in a multi-billion dollar market.

A key partnership, backed by the Saskatchewan government, is pioneering advanced DLE technology to unlock Canada's vast lithium brine resources for the EV market.

A Swedish biotech and Belgian university secure major EU funding to advance a first-in-class drug against glioblastoma, a notoriously deadly brain tumor.

Amid growing geopolitical risks, Danish firm Trifork has launched a sovereign data and AI solution, offering a local alternative for critical infrastructure.

Forget luxury yachts. Sweden's new contest offers a year on a private island, redefining escape for a world craving silence, nature, and simplicity.

After a soft 2025, Graphic Packaging's CEO faces investors. With the stock lagging, all eyes are on whether its green strategy can deliver growth.

A record-breaking drone and air taxi display at the Spring Festival Gala was more than a show; it was a bold statement on China's low-altitude economy.

Nearly half of UK couples struggle with hearing loss, eroding intimacy. A new campaign reveals why a hearing check may be more romantic than any gift.

Greece signs a landmark deal with Chevron and HELLENiQ for deep-sea hydrocarbon exploration, seeking energy independence amid high environmental stakes.

With a novel glutamate-targeting drug and a €38M cash injection, Newron aims to transform care for treatment-resistant schizophrenia.

A Virginia college's new solar project saves millions and trains the next generation of green energy workers, setting a new standard for the region.

The major CRO acquisition deepens Worldwide's oncology and FSP capabilities, signaling a strategic move in the consolidating clinical research market.

Manic Panic's new Inter-Gel-Actic collection features a revolutionary gel formula designed to make vibrant, at-home hair color easier than ever before.

A global alliance alleges a "drip-drip genocide" of Hindus in Bangladesh, citing a drastic population collapse and escalating violence under recent turmoil.

Acurx Pharmaceuticals preps for pivotal Phase 3 trials for its novel C. diff antibiotic, Ibezapolstat, with global regulatory alignment in place.

Amid unprecedented supply chain chaos, Westrock Coffee met its 100% responsible sourcing goal. Here's how they did it and what it means for the industry.

After a brutal 2024 and a massive strategy shift, all eyes are on Stellantis's 2025 earnings. Will the numbers justify its painful pivot away from EVs?

Zemcelpro® gains key reimbursement status, offering immediate hope and access for German patients with limited options and paving a new path for cell therapy.

AI biotech firm Juvenescence hires a top CTO and moves into Abu Dhabi, aiming to unlock anti-aging secrets with massive genomic data and AI.